Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction. Cancer Immunol Immunother. 2022 Dec; 71(12):2881-2898.
View in:
PubMed
subject areas
Antigens, Neoplasm
CD8-Positive T-Lymphocytes
Granzymes
Humans
Neoplasms
Receptors, Antigen, T-Cell
RNA, Messenger
T Cell Transcription Factor 1
authors with profiles
Junko Matsuzaki
Richard Koya
Takemasa Tsuji
Thinle Chodon